Affiliation:
1. Department of Gastroenterology, Kaiser Permanente San Francisco, San Francisco, CA
Abstract
ABSTRACT
Chronic octreotide use has been associated with gallstone formation. Historically, cholecystectomy has been the defining treatment for those who have gallstone-related disease. For those who are poor surgical candidates, percutaneous and endoscopic approaches have been used. We describe the endoscopic management of a 74-year-old man with significant gallstone burden and associated sequelae because of chronic octreotide for metastatic neuroendocrine tumor through endoscopic ultrasound-guided cholecystoduodenostomy with gallstone extraction using lumen-apposing metal stents.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference11 articles.
1. Why does somatostatin cause gallstones?;Ahrendt;Am J Surg.,1991
2. Octreotide-associated biliary tract dysfunction and gallstone formation: Pathophysiology and management;Redfern;Am J Gastroenterol.,1995
3. Endoscopic ultrasound-assisted transmural cholecystoduodenostomy or cholecystogastrostomy as a bridge for per-oral cholecystoscopy therapy using double-flanged fully covered metal stent;Ge;BMC Gastroenterol.,2016
4. EUS-guided gallbladder drainage: A review of current practices and procedures;James;Endosc Ultrasound.,2019
5. Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches;Cianci;World J Gastroenterol.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Octreotide;Reactions Weekly;2024-04-27